Craft

IMIDomics

Total Funding

$16.5 M

IMIDomics Summary

Company Summary

Overview
IMIDomics is a company that develops medicine diagnostics and therapeutics to optimize treatment of IMID (immune-mediated inflammatory diseases) patients. It utilizes a platform that integrates access to a dynamic IMID patient biobank, curated clinical data, proprietary multiomics molecular data, and clinical expertise. IMIDomics analytics platform extracts insights into disease biology and patient conditions through a proprietary interactive portal.
Type
Private
Status
Active
Founded
2015
Website
http://www.imidomics.com/
Cybersecurity rating
Sectors

Table of Contents

Footer menu